Emily Maier, Author at Woodruff Sawyer

Emily Maier

Senior Vice President, National Group Leader - M&A Insurance

Editor, Mergers & Acquisitions

Leading Woodruff Sawyers M&A practice, Emily provides consultation to clients seeking to minimize their risks associated with merger and acquisition activity. This includes Representations and Warranties, Tax Opinion Liability, and Litigation Buy-Out coverages. She has worked with both strategic and private equity buyers and sellers over a wide range of transaction sizes and industries, and is a frequent speaker and author on M&A transaction solutions.

emaier@woodruffsawyer.com

949.435.7378

Emily Maier

Senior Vice President, National Group Leader - M&A Insurance

Editor, Mergers & Acquisitions

emaier@woodruffsawyer.com

949.435.7378

INSIGHTS

Emily Maier

INSIGHTS

Coronavirus and Representations and Warranties Insurance

We have seen a variety of potential exclusions—ranging from very broad to more specific—for coronavirus, or COVID-19. We have every reason to believe exclusions will continue to be put in place on a standard basis at least for the time being. Learn more.

Emily Maier

Distressed Sales: Reps and Warranties Insurance Can Help in US and UK

Because of the impact of coronavirus on the economy, unfortunately, many businesses will take hits that prove fatal. As such, we expect to see a greater increase in the number of distressed sales.

Distressed Sales: Reps and Warranties Insurance Can Help

The bankruptcy process can be difficult to understand, so we've created simple guidance for how to make the most of Reps & Warranties insurance.

Cyber Representations and Warranties in M&A: A Growing Risk

We discuss the newly tracked representations (reps) related to privacy and cyber security and address the question: How would both representations and warranties insurance, and cyber insurance, respond to some of these new representations?

Representations and Warranties Culture Clash in International Deals

Learn how you can use the M&A representations and warranties insurance ("RWI") when acquiring foreign targets as well as international acquisitions in the United States.

Mind the Gap: Insurance Coverage Between the Sign and Close in M&A

This M&A Insight discusses the gap in coverage between signing and closing and what protections are in place during this interim period.

Five Ways an R&W Deal Can Go Sideways

More companies are utilizing R&W insurance on middle-market private equity, strategic, and M&A transactions. One notable trend is the arrival of relative newcomers to the marketplace implementing R&W insurance—specifically lower middle-market private equity funds, growth equity funds, and strategic investors. For newcomers and veterans alike, it is critical to understand the ways in which a process can go south—and how to keep things on track.

When the Excess Layer Doesn’t Respond: Novolex and Protecting Your Reps and Warranties Coverage

Learn about what excess layers are and how to ensure your reps & warranties coverage avoids the common and costly issues associated with excess layer wording.

Tax Liability Insurance: The Basics

There has been a large uptick in the availability and use of tax liability insurance in merger and acquisition deals. Learn what's covered with the product and the process for getting coverage.

Can You Insure Against Buying the Next Enron?

This article first appeared in Bloomberg Law on November 23, 2018

When purchasing a private company, the buyer might think that it is not in need of a representations and warranties insurance (“RWI”) policy if it has directors and officers (“D&O”) insurance.… More

Can You Insure Against the “Weinstein Clause” in M&A Deals?

This article first appeared in Bloomberg Law on October 4, 2018.

The #MeToo movement has affected many areas of everyday life from twitter rants to water cooler conversations and even Supreme Court justice confirmations.… More

Reps And Warranties Coverage In The Life Sciences Sector

The Life Sciences M&A market shows no sign of slowing down. The 2018 total value of life sciences M&A should once again surpass $200 billion. The lull in biopharma deal-making last year and the passage of US tax reform increase both desire and need for growth by acquisition, via M&A.

Representations and Warranties Insurance Buying Guide

Representations and Warranties insurance has gone from rarely used to commonplace in the last few years.… More